Chemi Nutra, LLC – Trademark Portfolio

Entity Type: 16

Chemi Nutra, LLC holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 16 trademarks are registered. Notable registered marks include ADHERE, MITOCL, IRONAID, SUCCEED, and HEPARAID. The owner is based in Austin, TX.

Suite 200D

11100 Metric Boulevard

Austin, TX 78758

22 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Chemi Nutra, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (11 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Chemi Nutra, LLC have?

Chemi Nutra, LLC has 22 U.S. trademarks filed with the USPTO. Of these, 16 registered, 5 abandoned, 1 cancelled.

What trademark classes does Chemi Nutra, LLC file in?

Chemi Nutra, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Chemi Nutra, LLC's most well-known trademarks?

Chemi Nutra, LLC's registered trademark portfolio includes well-known marks such as ADHERE, MITOCL, IRONAID, SUCCEED, and HEPARAID. These are among 16 currently registered trademarks in the portfolio.

What is Chemi Nutra, LLC's trademark registration success rate?

Chemi Nutra, LLC has a 73% trademark registration rate, with 16 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.